Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"HCC Screening"”.

  1. Measurement of Hepatocellular Carcinoma Screening and the Impact of Patient and Provider Factors on Screening Receipt, Early Tumor Detection and Overall Survival

    Hepatocellular carcinoma (HCC) is the 2nd leading cause of cancer-related death worldwide and the leading cause of death among patients with cirrhosis. HCC screening is highly recommended by professional societies to improve early tumor detection and survival, but is underused in clinical practice. …

    tamu Repository record for Measurement of Hepatocellular Carcinoma Screening and the Impact of Patient and Provider Factors on Screening Receipt, Early Tumor Detection and Overall Survival (opens in a new tab)

  2. Non-adherence to anti-viral therapy and utilisation of hepatocellular carcinoma screening among people living with chronic Hepatitis B in Sydney, Australia.

    … anti-viral therapy and hepatocellular carcinoma (HCC) screening have the potential to reduce HBV-related morbidity and mortality. However, little is known about non-adherence to HBV therapy globally and utilisation of HCC screening programs in Australia. This thesis describes factors influencing …

    unsw Repository record for Non-adherence to anti-viral therapy and utilisation of hepatocellular carcinoma screening among people living with chronic Hepatitis B in Sydney, Australia. (opens in a new tab)

  3. Retrospective Analysis Of Screening Patterns In Cirrhotic Patients With Heptocellular Carcinoma

    The incidence of hepatocellular carcinoma (HCC) in cirrhotic patients is increasing worldwide. Cirrhotic patients are recommended by the American Association for the Study of Liver Disease (AASLD) to receive HCC screening and surveillance every 6 months to a year. The purpose of this study was to …

    ucf Repository record for Retrospective Analysis Of Screening Patterns In Cirrhotic Patients With Heptocellular Carcinoma (opens in a new tab)

  4. Hepatocellular carcinoma screening reduces cancer-related mortality in patients with chronic hepatitis B infection: a case-control study

    … hepatitis B (CHB) infection often undergo screening for hepatocellular carcinoma (HCC), but the efficacy of such screening remains unclear. We aimed to evaluate the impact of screening with ultrasound (USS) and/or serum alpha-fetoprotein (AFP) on HCC-related mortality in Veterans Affairs …

    washington Repository record for Hepatocellular carcinoma screening reduces cancer-related mortality in patients with chronic hepatitis B infection: a case-control study (opens in a new tab)

  5. Evaluation of hepatitis B cascade of care and disease burden in New South Wales, Australia

    … cirrhosis (DC), hepatocellular carcinoma (HCC), and liver mortality trends are crucial for monitoring HBV elimination progress. Aims: Specific aims included assessing (1) trends in HBV-related DC and HCC diagnoses (including late HBV notification) and liver-related mortality, (2) …

    unsw Repository record for Evaluation of hepatitis B cascade of care and disease burden in New South Wales, Australia (opens in a new tab)

  6. IDENTIFICATION OF RARE AND COMMON GENETIC VARIANTS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: MECHANISMS AND CLINICAL IMPLICATIONS

    … the main cause of hepatocellular carcinoma (HCC) within 2025. Although the majority of NAFLD progressing towards HCC are individuals with advanced fibrosis, NAFLD-HCC frequently develops even in patients without cirrhosis. Family history and genetic factors play an important role in the …

    milano Repository record for IDENTIFICATION OF RARE AND COMMON GENETIC VARIANTS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: MECHANISMS AND CLINICAL IMPLICATIONS (opens in a new tab)

  7. El antígeno de células neoplásicas escamosas (SCCA) solo o formando el complejo SCCA-igM es un biomarcador precoz de carcinoma hepatocelular.

    Background: Hepatocellular carcinoma (HCC) represents more than 90% of primary liver cancers and is a major health problem. Every year more than 6.7 million deaths and 10.9 million new cancer cases were diagnosed. Early detection of HCC still is difficult due to the lack of adequate biomarkers that …

    sevilla Repository record for El antígeno de células neoplásicas escamosas (SCCA) solo o formando el complejo SCCA-igM es un biomarcador precoz de carcinoma hepatocelular. (opens in a new tab)